Your browser doesn't support javascript.
Inclusion of pregnant women in COVID-19 vaccine development.
Heath, Paul T; Le Doare, Kirsty; Khalil, Asma.
  • Heath PT; Paediatric Infectious Diseases Research Group and Vaccine Institute, Institute of Infection and Immunity, St George's University of London, London SW17 0RE, UK. Electronic address: pheath@sgul.ac.uk.
  • Le Doare K; Paediatric Infectious Diseases Research Group and Vaccine Institute, Institute of Infection and Immunity, St George's University of London, London SW17 0RE, UK; Medical Research Council/Uganda Virus Research Institute at London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda.
  • Khalil A; Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St George's University of London, London SW17 0RE, UK; Fetal Medicine Unit, St George's Hospital, London, UK.
Lancet Infect Dis ; 20(9): 1007-1008, 2020 09.
Article in English | MEDLINE | ID: covidwho-713482

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Viral Vaccines / Coronavirus Infections / Pandemics / Betacoronavirus Topics: Vaccines Limits: Female / Humans / Pregnancy Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Viral Vaccines / Coronavirus Infections / Pandemics / Betacoronavirus Topics: Vaccines Limits: Female / Humans / Pregnancy Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2020 Document Type: Article